Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05360771

Study on the Safety and Effectiveness of the SnowyTM PFO Closure System

A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Effectiveness of the SnowyTM PFO Closure System in Plugging Patent Foramen Ovale

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
242 (estimated)
Sponsor
Hangzhou Dinova EP Technology Co., Ltd · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To evaluate the safety and effectiveness of the SnowyTM PFO closure system in plugging patent foramen ovale

Detailed description

A prospective, multicenter, randomized controlled clinical trial is conducted to evaluate the safety and effectiveness of PFO closure system produced by Hangzhou Dinova EP Technology Co., Ltd.., Ltd. in closing patent foramen ovale (PFO). 242 patients are expected to be selected. They are randomly divided into the PFO closure system treatment group (121 cases) and the Chinese medicine Shengjie Cardi-o-fix PFO occluder treatment group (121 cases) according to 1:1. All patients will be followed up to 7 days after operation or before discharge, 1 month, 3 month, 6 month, 1 year, 2 year, 3 year, 4 year and 5 year.

Conditions

Interventions

TypeNameDescription
DEVICESnowyTM PFO closure systemPercutaneously occlusion of PFO with SnowyTM PFO closure system
DEVICECardi-o-fix PFO occluderPercutaneously occlusion of PFO with Cardi-o-fix PFO occluder

Timeline

Start date
2023-10-20
Primary completion
2023-12-20
Completion
2027-12-20
First posted
2022-05-04
Last updated
2023-06-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05360771. Inclusion in this directory is not an endorsement.